KRSNAA
NSEKrsnaa Diagnostics Limited (SMALL CAP)
Healthcare>Healthcare>Healthcare Services>Healthcare Service Provider
₹534.30
1.20 (0.23%)
High VOLATILITY
As on 12 Jun 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹1.73K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
17.0
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Healthcare Service Provider
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹515+3.7%
52W High₹894.4-40.3%
Current Price
₹534.30
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹427.44
Upper Circuit₹641.16
Reference Price
₹534.30
Investment Checklist
Triple Top on 1W (BREAKOUT CONFIRMED) — target ₹667.7
Head and Shoulders on 1W (BREAKOUT CONFIRMED) — target ₹537.9
Trend: Price below most MAs — downtrend | Bearish MA stack (20<50<200)
Composite score -42.14 (SELL) with 52.2% confidence
SuperTrend(10,3): Price below SuperTrend (Industry Standard (Swing/Medium-Term))
Technical Analysis
Technical Analysis
Analysis from 2026-06-12
Confidence
52%
Trend
BEARISH
BEARISH
Price below most MAs — downtrend | Bearish MA stack (20<50<200)
EMA20
550.54
EMA50
571.74
EMA200
666.53
Price Action
MIXED
NEUTRAL
Higher Highs4
Higher Lows3
Lower Highs5
Lower Lows6
Support & Resistance Levels
Resistance (Above)
₹578.78
₹621.18
₹630.35
₹654.25
₹670.00
Support (Below)
₹533.00
₹515.00
Volume Analysis
TrendDECREASING
Change-52.40%
Unusual VolumeNo
Stop Loss Levels
Fixed Risk
1% Risk₹528.96
3% Risk₹518.27
5% Risk₹507.58
7% Risk (Custom)
₹496.90Technical Levels
1x ATR (Volatility)₹515.03
2x ATR (Swing)₹495.76
3x ATR (Trend)₹476.49
Immediate Support₹533.00
Financials
Financial Analysis
| Metric | Mar '25 | Jun '25 | Sep '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹186.1 Cr | ₹193 Cr | ₹206 Cr | ₹181.2 Cr |
| Net Profit | ₹20.7 Cr | ₹20.5 Cr | ₹23.9 Cr | ₹15.2 Cr |
| EPS | — | ₹6.35 | ₹7.38 | ₹4.72 |
| Operating Profit | ₹54.5 Cr | ₹55.4 Cr | ₹63.3 Cr | ₹50.1 Cr |
ROE
8.79%
ROCE
11.46%
Debt/Equity
0.23
Current Ratio
1.36
OPM
27.66%
NPM
8.41%
Peer Comparison
Healthcare Service ProviderPeer Comparison
| Symbol | Name | Price | Change |
|---|---|---|---|
| LALPATHLAB | Dr. Lal Path Labs Ltd. | ₹1,601.50 | +0.50% |
| VIJAYA | Vijaya Diagnostic Centre Limited | ₹1,287.20 | +0.63% |
| THYROCARE | Thyrocare Technologies Limited | ₹528.90 | +1.83% |
| NEPHROPLUS | Nephrocare Health Services Limited | ₹748.15 | -0.42% |
| METROPOLIS | Metropolis Healthcare Limited | ₹530.70 | +2.03% |
| SURAKSHA | Suraksha Diagnostic Limited | ₹268.05 | +0.00% |
| 3BBLACKBIO | 3B Blackbio Dx Limited | ₹1,245.40 | -0.69% |
| HEALTHX | Health X Platform Limited | ₹280.90 | +0.90% |
| CHANDAN | Chandan Healthcare Limited | ₹226.80 | +1.18% |
| INVICTA | Invicta Diagnostic Limited | ₹59.95 | -1.72% |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 12 Sept 2025 | Dividend - Rs 2.75 Per Share | DIVIDEND |
| 13 Sept 2024 | Dividend - Rs 2.50 Per Share | DIVIDEND |
| 13 Sept 2024 | Annual General Meeting | AGM |
| 15 Sept 2023 | Annual General Meeting | AGM |
| 15 Sept 2023 | Dividend - Rs 2.75 Per Share | DIVIDEND |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for KRSNAA
View AllNEWS
positive
Business Standard - Markets 18d ago
Krsnaa Diagnostics Q4 PAT climbs 102% YoY to Rs 42 cr
Krsnaa Diagnostics reported a 101.74% increase in consolidated net profit to Rs 41.72 crore in Q4 FY26 from Rs 20.68 crore posted in Q4 FY25.
KRSNAAHealthcare
NEWS
positive
Business Standard - Markets 18d ago
Krsnaa Diagnostics consolidated net profit rises 101.74% in the March 2026 quarter
Sales rise 3.50% to Rs 192.60 crore
KRSNAAHealthcare